Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

54.50p
   
  • Change Today:
    -1.50p
  • 52 Week High: 82.50
  • 52 Week Low: 27.50
  • Currency: UK Pounds
  • Shares Issued: 436.45m
  • Volume: 3,389,106
  • Market Cap: £237.86m
  • RiskGrade: 461
  • Beta: 0.75

Avacta Group Overview

Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION™ platforms.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Avacta Group Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 2.14 (18.86) (7.27)p n/a n/a n/a n/a 0.0%
31-Dec-21 2.94 (29.19) (10.57)p n/a n/a n/a n/a 0.0%
31-Dec-22 9.65 (41.64) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 2.85 (31.12) (10.69)p n/a n/a n/a n/a 0.0%
31-Dec-24 0.11 (28.98) (8.54)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Avacta Group Company Announcements

Faridoxorubicin Phase 1b SGC data 17-Dec-2025 07:00 RNS
Preliminary Data in Faridoxorubicin Phase 1b Trial 08-Dec-2025 07:00 RNS
Completion of Placing and TVR 03-Nov-2025 08:24 RNS

Avacta Group ShareCast News

Avacta upbeat on fresh data from second oncology... 18-Dec-2025 ShareCast
Avacta reports 'clinically meaningful' tumour sh... 17-Dec-2025 ShareCast
Avacta presents promising findings to Boston con... 27-Oct-2025 ShareCast

Latest Avacta Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 54.50p
Change Today -1.50p
% Change -2.68 %
52 Week High 82.50
52 Week Low 27.50
Volume 3,389,106
Shares Issued 436.45m
Market Cap £237.86m
Beta 0.75
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.32% below the market average36.32% below the market average36.32% below the market average36.32% below the market average36.32% below the market average
46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average
Price Trend
37.22% below the market average37.22% below the market average37.22% below the market average37.22% below the market average37.22% below the market average
13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average
Income Not Available
Growth
40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average
58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average

Avacta Group Dividends

No dividends found

Trades for 13-Jan-2026

Time Volume / Share Price
17:07 50,000 @ 54.50p
16:28 2,804 @ 53.77p
16:24 2,798 @ 53.77p
16:22 2,710 @ 54.90p
16:18 4,546 @ 54.90p

Avacta Group Key Personnel

CEO Christina Coughlin

Top of Page